BroadOak Capital Partners, LLC is a privately held investment bank with a comprehensive focus on the life sciences industry. We offer advisory services including mergers and acquisitions, divestitures, business combinations, joint ventures, valuations and fairness opinions. We also engage in principal investment activities, including co-investments, as particularly compelling opportunities arise. Our sector focus includes research tools and consumables, diagnostics, therapeutics, healthcare IT, pharmaceutical services and medical devices.
BroadOak provides multinational, middle-market and entrepreneurial clients with the customized attention of a boutique while delivering a range of expertise more typically associated with a larger firm. Our industry focus allows the firm’s principals to target their investment banking experience and insight to specific client needs.
News
- Albany Molecular Research, Inc. acquires Hyaluron, Inc.
- Molecular Transfer, Inc. acquires GlobalStem, Inc.
- Caliper’s in-vivo preclinical CRO services business is acquired by Taconic Farms, Inc.
- Alpha Innotech Corp. is acquired by Cell Biosciences, Inc.
- Orion Genomics in collaboration with Novartis AG